Marshall Wace’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Marshall Wace’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-206	Closed	-$129K	–	3195
2021 Q1	$129K	Buy	+206	New	+$132K	﹤0.01%	2329

Other funds holding VCNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace's VCNX Position: Q2 2021 in Review

Marshall Wace sold out of Vaccinex, Inc. Common Stock (VCNX) in Q2 2021, closing a stake of 206 shares — an estimated $129K sold.

Marshall Wace first reported a position in VCNX in Q1 2021 and held it in 1 quarter. The position peaked at $129K in Q1 2021. 24 funds tracked by Wall St. Rank hold VCNX as of Q2 2021.

Marshall Wace reported no remaining Vaccinex, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Marshall Wace sold 206 Vaccinex, Inc. Common Stock shares in Q2 2021, an estimated $129K.
Marshall Wace first reported a position in Vaccinex, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Marshall Wace's Vaccinex, Inc. Common Stock position peaked at $129K in Q1 2021.
24 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.